Uysal, M. Et Al. 2014. Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer. JOURNAL OF BUON , vol.19, no.4 , 980-984.

Uysal, M., OZDOGAN, M., KARGI, A., GUNDUZ, S., GOKSU, S. S., TATLI, A. M., ... ARSLAN, D.(2014). Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer. JOURNAL OF BUON , vol.19, no.4, 980-984.

Uysal, SEMA Et Al. "Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer," JOURNAL OF BUON , vol.19, no.4, 980-984, 2014

Uysal, SEMA S. Et Al. "Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer." JOURNAL OF BUON , vol.19, no.4, pp.980-984, 2014

Uysal, M. Et Al. (2014) . "Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer." JOURNAL OF BUON , vol.19, no.4, pp.980-984.

@article{article, author={SEMA SEZGİN GÖKSU Et Al. }, title={Prolonged progression-free survival with maintenance metronomic oral cyclophosphamide and etoposide treatment in macroscopic residual disease or recurrent/advanced stage ovarian cancer}, journal={JOURNAL OF BUON}, year=2014, pages={980-984} }